The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies.
Open accessAbstract
The pleiotropic cyto/lymphokine tumor necrosis factor (TNF) exerts its functions by binding to specific cell-surface receptors. We have prepared two sets of monoclonal antibodies (mAbs) against TNF-binding proteins from the HL-60 (htr-mAb series) and U-937 (utr-mAb series) cell lines. The htr antibodies inhibit the binding of 125I-labeled TNF-alpha to HL-60 cells only partially, whereas they block the TNF-alpha binding to several adenocarcinoma cell lines (HEp-2, HeLa, and MCF7) almost completely. In contrast, the utr antibodies have no effect on TNF-alpha binding to the adenocarcinoma cell lines but partially inhibit TNF-alpha binding to HL-60 and U-937 cells. However, htr-9 and utr-1 antibodies in combination fully inhibit the TNF-alpha binding to HL-60 and U-937 cells. The binding of TNF-beta to HEp-2 and U-937 cells is also inhibited by htr and utr antibodies. Neither htr nor utr mAb has an effect on the TNF-sensitive murine cell lines L929 and WEHI 164. Flow cytometry studies show that mAbs htr-9 and utr-1 detect two distinct TNF-binding sites on human cell lines. Immunologic blot and immunoprecipitation analyses indicate that mAbs htr-9 and utr-1 recognize proteins of approximately 55 kDa and 75 kDa, respectively. These data provide evidence for the existence of two distinct TNF receptor molecules that contribute to varying extent to the TNF binding by different human cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Fraker, P. J., & Speck, J. C. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)91322-0 · Cited by 4,558
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., Zentella, A., Albert, J. D., et al. (1986) · Science · doi:10.1126/science.3764421 · Cited by 2,549
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin
Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., & Goeddel, D. V. (1984) · Nature · doi:10.1038/312724a0 · Cited by 1,736
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
Trauth, B. C., Klas, C., Peters, A. M. J., Matzku, S., Möller, P., Falk, W., Debatin, K.-M., & Krammer, P. H. (1989) · Science · doi:10.1126/science.2787530 · Cited by 1,716
Cachectin: More Than a Tumor Necrosis Factor
Epstein, F. H., Beutler, B., & Cerami, A. (1987) · New England Journal of Medicine · doi:10.1056/nejm198702123160705 · Cited by 1,432
Yonehara, S., Ishii, A., & Yonehara, M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.5.1747 · Cited by 1,400
Kindler, V., Sappino, A.-P., Grau, G. E., Piguet, P.-F., & Vassalli, P. (1989) · Cell · doi:10.1016/0092-8674(89)90676-4 · Cited by 1,254
Cited by
The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S.-I., Sameshima, M., Hase, A., Seto, Y., & Nagata, S. (1991) · Cell · doi:10.1016/0092-8674(91)90614-5 · Cited by 2,737
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
Choy, E. H. S., & Panayi, G. S. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103223441207 · Cited by 2,249
Grell, M., Douni, E., Wajant, H., Löhden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90192-2 · Cited by 1,325
Self-citationA novel domain within the 55 kd TNF receptor signals cell death
Tartaglia, L. A., Ayres, T. M., Wong, G. H. W., & Goeddel, D. V. (1993) · Cell · doi:10.1016/0092-8674(93)90464-2 · Cited by 1,288
Neutrophils: Molecules, Functions and Pathophysiological Aspects
Witko-Sarsat, V., Rieu, P., Descamps-Latscha, B., Lesavre, P., & Halbwachs-Mecarelli, L. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780067 · Cited by 1,135
Evidence of a Role of Tumor Necrosis Factor α in Refractory Asthma
Berry, M. A., Hargadon, B., Shelley, M., Parker, D., Shaw, D. E., Green, R. H., Bradding, P., Brightling, C. E., Wardlaw, A. J., & Pavord, I. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa050580 · Cited by 826
The two different receptors for tumor necrosis factor mediate distinct cellular responses.
Tartaglia, L. A., Weber, R. F., Figari, I. S., Reynolds, C., Palladino, M. A., & Goeddel, D. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9292 · Cited by 807
Tumor necrosis factor Characterization at the molecular, cellular and in vivo level
Fiers, W. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80803-b · Cited by 694
Erickson, S. L., de Sauvage, F. J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheehan, K. C. F., Schreiber, R. D., Goeddel, D. V., & Moore, M. W. (1994) · Nature · doi:10.1038/372560a0 · Cited by 588
Lewis, M., Tartaglia, L. A., Lee, A., Bennett, G. L., Rice, G. C., Wong, G. H., Chen, E. Y., & Goeddel, D. V. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2830 · Cited by 567
Tartaglia, L. A., Pennica, D., & Goeddel, D. V. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46661-0 · Cited by 562
Zhu, C.-B., Blakely, R. D., & Hewlett, W. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301029 · Cited by 549
Serum Inflammatory Markers in Obstructive Sleep Apnea: A Meta-Analysis
Nadeem, R., Molnar, J., Madbouly, E. M., Nida, M., Aggarwal, S., Sajid, H., Naseem, J., & Loomba, R. (2013) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.3070 · Cited by 481
Elevated tumour necrosis factor-alpha (TNF-α) biological activity in psoriatic skin lesions
ETTEHADI, P., GREAVES, M. W., WALLACH, D., ADERKA, D., & CAMP, R. D. R. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1994.tb06244.x · Cited by 481
The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor
Grell, M., Wajant, H., Zimmermann, G., & Scheurich, P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.570 · Cited by 478
Sandborn, W. J., & Hanauer, S. B. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199905000-00008 · Cited by 454
Dressler, K. A., Mathias, S., & Kolesnick, R. N. (1992) · Science · doi:10.1126/science.1313189 · Cited by 440
Shedding of tumor necrosis factor receptors by activated human neutrophils.
Porteu, F., & Nathan, C. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.2.599 · Cited by 437
Signal transduction by tumor necrosis factor receptors
Cabal-Hierro, L., & Lazo, P. S. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.02.006 · Cited by 436
Mackay, F., Loetscher, H., Stueber, D., Gehr, G., & Lesslauer, W. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.5.1277 · Cited by 395
Self-citationGukovskaya, A. S., Gukovsky, I., Zaninovic, V, Song, M., Sandoval, D., Gukovsky, S., & Pandol, S. J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119714 · Cited by 384
FAN, a Novel WD-Repeat Protein, Couples the p55 TNF-Receptor to Neutral Sphingomyelinase
Adam-Klages, S., Adam, D., Wiegmann, K., Struve, S., Kolanus, W., Schneider-Mergener, J., & Krönke, M. (1996) · Cell · doi:10.1016/s0092-8674(00)80169-5 · Cited by 381
Vernooy, J. H., Küçükaycan, M., Jacobs, J. A., Chavannes, N. H., Buurman, W. A., Dentener, M. A., & Wouters, E. F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2202023 · Cited by 379
Targeting TNF-α: A novel therapeutic approach for asthma
Brightling, C., Berry, M., & Amrani, Y. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.10.028 · Cited by 363
A potential role of macrophage activation in the treatment of cancer
Klimp, A. H., de Vries, E. G. E., Scherphof, G. L., & Daemen, T. (2002) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00203-7 · Cited by 360
Cope, A. P., Gibbons, D., Brennan, F. M., Feldmann, M., Aderka, D., Doherty, M., Jones, A. C., Engelmann, H., Wallach, D., & Maini, R. N. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351008 · Cited by 337
Tumor Necrosis Factor α Inhibits Glutamate Uptake by Primary Human Astrocytes
Fine, S. M., Angel, R. A., Perry, S. W., Epstein, L. G., Rothstein, J. D., Dewhurst, S., & Gelbard, H. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15303 · Cited by 324
Panoskaltsis-Mortari, A., Griese, M., Madtes, D. K., Belperio, J. A., Haddad, I. Y., Folz, R. J., & Cooke, K. R. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2007-413st · Cited by 313
Griffioen, A., Damen, C., Blijham, G., & Groenewegen, G. (1996) · Blood · doi:10.1182/blood.v88.2.667.bloodjournal882667 · Cited by 304
Talley, A. K., Dewhurst, S., Perry, S. W., Dollard, S. C., Gummuluru, S., Fine, S. M., New, D., Epstein, L. G., Gendelman, H. E., & Gelbard, H. A. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2359 · Cited by 302
Da Silva, J., Pierrat, B., Mary, J.-L., & Lesslauer, W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.45.28373 · Cited by 301
Self-citationGrell, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3034 · Cited by 284
Hack, C. E., Aarden, L. A., & Thus, L. G. (1997) · Advances in Immunology · doi:10.1016/s0065-2776(08)60597-0 · Cited by 280
Mantzoros, C. S., Moschos, S., Avramopoulos, I., Kaklamani, V., Liolios, A., Doulgerakis, D. E., Griveas, I., Katsilambros, N., & Flier, J. S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.10.4323 · Cited by 274
The p70 tumor necrosis factor receptor mediates cytotoxicity
Holler, R. A., Song, K., Fan, N., & Chang, D. J. (1992) · Cell · doi:10.1016/0092-8674(92)90532-h · Cited by 266
Song, H. Y., Dunbar, J. D., Zhang, Y. X., Guo, D., & Donner, D. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.3574 · Cited by 264
Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences
Dembic, Z., Loetscher, H., Gubler, U., Pan, Y.-C. E., Lahm, H.-W., Gentz, R., Brockhaus, M., & Lesslauer, W. (1990) · Cytokine · doi:10.1016/1043-4666(90)90022-l · Cited by 261
Self-citationCytokines in osteoarthritis: Mediators or markers of joint destruction?
Westacott, C. I., & Sharif, M. (1996) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(96)80036-9 · Cited by 256
Mackowiak, P. A. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.17.1870 · Cited by 254
Naylor, M. S., Stamp, G. W., Foulkes, W. D., Eccles, D., & Balkwill, F. R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116446 · Cited by 252
Trefzer, U., Brockhaus, M., Lötscher, H., Parlow, F., Budnik, A., Grewe, M., Christoph, H., Kapp, A., Schöpf, E., & Luger, T. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116589 · Cited by 91
Self-citationGlossop, J. R., Dawes, P. T., & Mattey, D. L. (2006) · Rheumatology · doi:10.1093/rheumatology/kel094 · Cited by 86
Refractory ulcers: The role of tumor necrosis factor–α
Weinstein, D. A., & Kirsner, R. S. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.08.004 · Cited by 33
Metadata
- Authors
- Brockhaus, M., Schoenfeld, H. J., Schlaeger, E. J., Hunziker, W., Lesslauer, W., & Loetscher, H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1990-04
- Volume
- 87
- Issue
- 8
- Pages
- 3127-3131
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2078917040
- Cited by
- 661
- References
- 21
- FWCI
- 22.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.